You are searching for: hsa04380

---

T20178 Target Info	Target Name	Tumor necrosis factor (TNF)
	Target type	Successful Target
	Disease	Intermittent claudication; Multiple myeloma;
	Drugs	Adalimumab	Drug Info

T22212 Target Info	Target Name	Immunoglobulin gamma Fc receptor IIA (FCGR2A)
	Target type	Successful Target
	Disease	Idiopathic thrombocytopenic purpura; Systemic lupus erythematosus;
	Drugs	SM-101	Drug Info

T06421 Target Info	Target Name	Interferon alpha/beta receptor 2 (IFNAR2)
	Target type	Successful Target
	Disease	Hepatitis C; Hairy cell leukaemia;
	Drugs	Anifrolumab	Drug Info

T30284 Target Info	Target Name	Interferon gamma receptor (IFNGR2)
	Target type	Successful Target
	Disease	Chronic granulomatous disease; Systemic lupus erythematosus;
	Drugs	Anifrolumab	Drug Info

T02808 Target Info	Target Name	Interferon-beta (IFNB1)
	Target type	Successful Target
	Disease	Type-2 diabetes; Acute lung injury;
	Drugs	PEGylated IFN beta 1-a	Drug Info

T97257 Target Info	Target Name	Transforming growth factor beta 1 (TGFB1)
	Target type	Successful Target
	Disease	Idiopathic pulmonary fibrosis; Aggressive cancer;
	Drugs	Pirfenidone	Drug Info

T99057 Target Info	Target Name	HUMAN ERK activator kinase 1 (MEK1)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T11388 Target Info	Target Name	Cathepsin K (CTSK)
	Target type	Clinical trial Target
	Disease	Bone cancer; Chronic obstructive pulmonary disease;
	Drugs	Odanacatib	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.